Third-generation-cephalosporin-resistant Klebsiella pneumoniae isolates from humans and companion animals in Switzerland: spread of a DHA-producing sequence type 11 clone in a veterinary setting

Antimicrobial Agents and Chemotherapy
Nadia WohlwendVincent Perreten

Abstract

Characterization of third-generation-cephalosporin-resistant Klebsiella pneumoniae isolates originating mainly from one human hospital (n = 22) and one companion animal hospital (n = 25) in Bern (Switzerland) revealed the absence of epidemiological links between human and animal isolates. Human infections were not associated with the spread of any specific clone, while the majority of animal infections were due to K. pneumoniae sequence type 11 isolates producing plasmidic DHA AmpC. This clonal dissemination within the veterinary hospital emphasizes the need for effective infection control practices.

Citations

Dec 23, 2015·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Zi-Ke ShengMinggui Wang
Jun 18, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Dorina TimofteVanessa Schmidt
Feb 2, 2017·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J-Y MadecL Poirel
Apr 12, 2017·Antimicrobial Agents and Chemotherapy·Cristina M OvejeroBruno Gonzalez-Zorn
Feb 29, 2020·Animals : an Open Access Journal From MDPI·Eddy SukmawinataMasuo Sueyoshi
Jul 31, 2019·Antimicrobial Agents and Chemotherapy·Mathieu ClémentAndrea Endimiani
Oct 3, 2019·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Aurélien NiggVincent Perreten

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.